Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06

B*38:01 and B*39:06 are present with phenotypic frequencies <2 % in the general population, but are of interest as B*39:06 is the B allele most associated with type 1 diabetes susceptibility and 38:01 is most protective. A previous study derived putative main anchor motifs for both alleles based on peptide elution data. The present study has utilized panels of single amino acid substitution peptide libraries to derive detailed quantitative motifs accounting for both primary and secondary influences on peptide binding. From these analyses, both alleles were confirmed to utilize the canonical position 2/C-terminus main anchor spacing. B*38:01 preferentially bound peptides with the positively charged or polar residues H, R, and Q in position 2 and the large hydrophobic residues I, F, L, W, and M at the C-terminus. B*39:06 had a similar preference for R in position 2, but also well-tolerated M, Q, and K. A more dramatic contrast between the two alleles was noted at the C-terminus, where the specificity of B*39:06 was clearly for small residues, with A as most preferred, followed by G, V, S, T, and I. Detailed position-by-position and residue-by-residue coefficient values were generated from the panels to provide detailed quantitative B*38:01 and B*39:06 motifs. It is hoped that these detailed motifs will facilitate the identification of T cell epitopes recognized in the context of two class I alleles associated with dramatically different dispositions towards type 1 diabetes, offering potential avenues for the investigation of the role of CD8 T cells in this disease.

[1]  A Sette,et al.  The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. , 2001, Biologicals : journal of the International Association of Biological Standardization.

[2]  J. Granados,et al.  Intron 2 and exon 3 sequences may be involved in the susceptibility to develop Takayasu arteritis. , 1998, International journal of cardiology.

[3]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[4]  H. Rammensee,et al.  Peptide motifs of HLA-B38 and B39 molecules , 2004, Immunogenetics.

[5]  E. Yunis,et al.  Association of HLA-DRB1*1602 and DRB1*1001 with Takayasu arteritis in Colombian mestizos as markers of Amerindian ancestry. , 2000, International journal of cardiology.

[6]  J. Sidney,et al.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.

[7]  E. Leiter,et al.  Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis Resistant , 1994, Diabetes.

[8]  J. Shabanowitz,et al.  Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. , 2010, International immunology.

[9]  D. Vignali,et al.  T cell-driven initiation and propagation of autoimmune diabetes. , 2011, Current opinion in immunology.

[10]  N. Rezaei,et al.  Association of human leukocyte antigen class I antigens in Iranian patients with pemphigus vulgaris , 2013, The Journal of dermatology.

[11]  A. Sette,et al.  Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. , 2003, Current opinion in immunology.

[12]  S. Baranzini,et al.  Genetic contribution to multiple sclerosis risk among Ashkenazi Jews , 2015, BMC Medical Genetics.

[13]  Bjoern Peters,et al.  Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.

[14]  J. Carlson,et al.  HLA Class I and Genetic Susceptibility to Type 1 Diabetes , 2010, Diabetes.

[15]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[16]  P. Santamaria,et al.  CD8+ T cells in autoimmunity. , 2005, Current opinion in immunology.

[17]  M Peakman,et al.  Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06. , 2014, Tissue antigens.

[18]  D. Clayton,et al.  Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA‐B and HLA‐A , 2009, Diabetes, obesity & metabolism.

[19]  J. Rosmalen,et al.  T-cell education in autoimmune diabetes: teachers and students. , 2002, Trends in immunology.

[20]  Morten Nielsen,et al.  A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules , 2006, PLoS Comput. Biol..

[21]  Alessandro Sette,et al.  Reverse vaccinology: developing vaccines in the era of genomics. , 2010, Immunity.

[22]  Simon C. Potter,et al.  Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A , 2007, Nature.

[23]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[24]  Clemencia Pinilla,et al.  Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.

[25]  K. Frauwirth,et al.  Peripheral tolerance in CD8+ T cells. , 2009, Cytokine.

[26]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[27]  M. Soto,et al.  Comparative study of the residues 63 and 67 on the HLA-B molecule in patients with Takayasu's Arteritis. , 2005, Immunology letters.

[28]  A Sette,et al.  Tools of the Trade in Vaccine Design , 2000, Science.

[29]  M. Atkinson,et al.  Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients , 2012, The Journal of experimental medicine.

[30]  Bjoern Peters,et al.  Immune epitope mapping in the post-genomic era: lessons for vaccine development. , 2007, Current opinion in immunology.

[31]  John Sidney,et al.  Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Sewell,et al.  Human β-Cell Killing by Autoreactive Preproinsulin-Specific CD8 T Cells Is Predominantly Granule-Mediated With the Potency Dependent Upon T-Cell Receptor Avidity , 2012, Diabetes.

[33]  Meenu R Pillai,et al.  The development and function of regulatory T cells , 2009, Cellular and Molecular Life Sciences.

[34]  J. Sidney,et al.  The role of MHC class I allele Mamu-A*07 during SIVmac239 infection , 2011, Immunogenetics.

[35]  Michel C Nussenzweig,et al.  Tolerogenic dendritic cells. , 2003, Annual review of immunology.

[36]  Morten Nielsen,et al.  Automated benchmarking of peptide-MHC class I binding predictions , 2015, Bioinform..

[37]  T. DiLorenzo,et al.  Glucagon‐reactive islet‐infiltrating CD8 T cells in NOD mice , 2015, Immunology.